Results about: metastasis dormancy

<p>Gomis</p>

Intricate signalling networks control cell division, differentiation, movement, organization and death. Understanding how cells read and transform these signals into changes in cell behaviour is a major research focus of our group.

Joan Massagué calls on society to get on board with the challenge posed by metastasis

High-ranking figures from the business and innovation sectors attended an event organised by IRB Barcelona and ESADE with the aim to highlight the importance of uniting all sectors of society against metastasis.

Cancer metastases slowly unveil their weaknesses

Advances in research into the immunological evasion, metabolism and latency of metastatic cancer cells allow the identification of potential targets to test therapies.

IRB Barcelona and the BBVA Foundation invite 20 renowned international scientists working in the field of cancer metastasis to a gathering in Barcelona.

After the scientific conference, IRB Barcelona and ESADE have organised a debate on how to translate scientific research to society.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

A team of scientists headed by Roger Gomis at IRB Barcelona reveals one of the mechanisms that allows metastatic cells to leave a latent state.

“Questions are raised when dealing with patients, but are answered in the laboratory.”

Juan Miguel Cejalvo (Valencia, 1984), an oncologist trained at the Hospital Clínico Universitario de Valencia, has been selected to do his thesis at IRB Barcelona under the PhD for Medical Doctors (PhD4MD) programme. He has already joined Roger Gomis’ Growth Control and Cancer Metastasis group, where he will perform the basic research for his project. Aleix Prat, from IDIBAPS, will lead the clinical part of this project. Both Roger Gomis and Aleix Prat have extensive experience in cancer research, especially breast cancer and metastasis. Promoted by IRB Barcelona, CRG, IDIBAPS and VHIR, the PhD4MD programme seeks to train a new generation of physician-scientists in order to facilitate the transfer of biomedical discoveries to patients.